Back to search
FDAFDA · Food and drugs·Recall number Z-0722-2017

Barbiturates Intercept Micro-Plate EIA (enzyme immunoassay, barbiturate) Product is intended for use by clinical laboratories in the qualitative determination of barbiturates in oral fluids.

Published December 14, 2016 · Recall initiated: November 10, 2016

Summary

FDA records medical device Class III recall Z-0722-2017, published December 14, 2016 and initiated November 10, 2016. Recalling firm: OraSure Technologies, Inc.; Status: Terminated; Reported quantity: 4 kits; Lot: Lot # 6654085. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Shipping error. Cocaine metabolite Microplate distributed instead of Barbiturate Microplate due to incorrect selection of Microplate during manufacturing.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
OraSure Technologies, Inc.
Distributor
Distributed to KS, and VA
Lot
Lot # 6654085
Risk classification
Class III
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Barbiturates Intercept Micro-Plate EIA (enzyme immunoassay, barbiturate) Product is intended for use by clinical laboratories in the qualitative determination of barbiturates in oral fluids. recalled?

Yes. FDA published recall Z-0722-2017 on December 14, 2016. Reported hazard: Shipping error. Cocaine metabolite Microplate distributed instead of Barbiturate Microplate due to incorrect selection of Microplate during manufacturing.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone